250 related articles for article (PubMed ID: 25592281)
1. Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.
Noguchi E; Saito N; Kobayashi M; Kameoka S
Mol Med Rep; 2015 May; 11(5):3423-31. PubMed ID: 25592281
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis.
Zhang N; Xie F; Gao W; Yu S; Qiu L; Lin W; Sun Y; Jia T
Mol Med Rep; 2015 Apr; 11(4):2797-804. PubMed ID: 25504327
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of the hepatocyte growth factor contributing to lymphangiogenesis and lymphatic metastasis in gastric cancer].
Zhang QH; Qian K; Li XJ; Pu J; Wu XT
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):212-6. PubMed ID: 17520376
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy.
Serilmez M; Özgür E; Karaman S; Gezer U; Duranyıldız D
Cancer Biomark; 2019; 25(2):177-184. PubMed ID: 31104010
[TBL] [Abstract][Full Text] [Related]
7. [Expression of hepatocyte growth factor and its receptor in gastric cancer].
Chen JZ; Zhao Y; Xu JF; Liu Q; Liu SH; Zhang HD
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1771-3. PubMed ID: 18024311
[TBL] [Abstract][Full Text] [Related]
8. c-Met expression in gastric cancer with liver metastasis.
Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
[TBL] [Abstract][Full Text] [Related]
9. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
10. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
Zhao ZS; Ru GQ; Ma J
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma.
Ramirez R; Hsu D; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
Clin Endocrinol (Oxf); 2000 Nov; 53(5):635-44. PubMed ID: 11106926
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma.
Koo BS; Kim JM; Seo ST; Yoon YH; Kwon KR; Kim SH; Kwon HW; Bae WJ; Lim YC
Ann Surg Oncol; 2014 Jul; 21(7):2310-7. PubMed ID: 24562934
[TBL] [Abstract][Full Text] [Related]
13. Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.
Gao LM; Wang F; Zheng Y; Fu ZZ; Zheng L; Chen LL
Pathol Oncol Res; 2019 Jan; 25(1):369-376. PubMed ID: 29134462
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Fujikawa H; Matsushita K; Okugawa Y; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Int J Oncol; 2012 Feb; 40(2):583-91. PubMed ID: 21922134
[TBL] [Abstract][Full Text] [Related]
17. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
Ferrucci A; Moschetta M; Frassanito MA; Berardi S; Catacchio I; Ria R; Racanelli V; Caivano A; Solimando AG; Vergara D; Maffia M; Latorre D; Rizzello A; Zito A; Ditonno P; Maiorano E; Ribatti D; Vacca A
Clin Cancer Res; 2014 Nov; 20(22):5796-807. PubMed ID: 25212607
[TBL] [Abstract][Full Text] [Related]
18. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
Murakami N; Koufuji K; Shirouzu K
Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
[TBL] [Abstract][Full Text] [Related]
20. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]